By proceeding, you agree to our Terms of Use and Privacy Policy.
The 6th Annual Dermatology Drug Development Summit for Inflammatory Skin Diseases returns to Boston this fall. Amidst the immense range and a steady stream of the novel, topical, and systemic agents entering exciting early phases, now is the time to gain insight from other leaders in the space.
Navigate specificity & safety roadblocks to advance efficacious therapies for chronic dermatological diseases, at this event.
Discover the evaluations on critical inflammatory, auto-immune pathways, gain insights on promising biologics targeting IL-13, IL-31, IL-33, VS IL-17 linked diseases.
When it comes to moderate-to-severe inflammatory skin conditions you’ll find genetic discoveries, antibody drug development, new delivery strategies here!
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Nordic Bioscience is the leading expert in extracellular matrix (ECM) research with 25+ years of experience in biomarker development, pre-clinical and clinical research.
OM1 is a leading health outcomes and registries company focused on the measurement, comparison, and prediction of treatment outcomes.
SCARLETRED is a MedTech company transforming the global dermatology market.
At DermTech we bring precision to the practice of dermatology through non-invasive genomic testing. And we developed the Smart Sticker™ that's making it possible.
CPL is a leading contract development and manufacturing organization (CDMO) that provides development, manufacturing, packaging, and testing of non-sterile liquid and semi-solid pharmaceutical and regulated OTC products.
Dow Development Laboratories (DDL) designs, develops, tests and manufactures topical drug products, including creams, gels, ointments, pastes, solutions, and suspensions.
As a leading contract development and manufacturing organization, DPT is recognized for our expertise in semi-solid and liquid dosage forms, with an established legacy of excellence dating back 80 years.
Founded in Europe, NUVISAN is a fully integrated Contract Research Organization with a 40-year track record of serving clients’ needs in early and clinical development for pharmaceutical and biotech companies, academic institutes and CROs.
QuantifiCare is a fast growing leading Imaging CRO offering: - Pre-clinical to phase IV clinical trial services across a wide range of clinical areas to pharmaceutical, biotech and cosmetic industries.
Tergus Pharma is an end-to-end service provider for topical pharmaceutical products supporting early phase research and formulation, drug development, testing, and both clinical and commercial manufacturing at our new 100,000 sq. ft.
Therapeutics Inc. is a drug research and development company focusing on integration of clinical and regulatory strategies, trial design, product development, and marketplace analysis.
As a full-service CRO with independent clinical sites, we possess a deeper insight into the intricacies of study design, recruiting and budgeting.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.